Literature DB >> 23673863

Umbilical cord blood transplantation: the first 25 years and beyond.

Karen K Ballen1, Eliane Gluckman, Hal E Broxmeyer.   

Abstract

Umbilical cord blood is an alternative hematopoietic stem cell source for patients with hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation. Initially, umbilical cord blood transplantation was limited to children, given the low cell dose infused. Both related and unrelated cord blood transplants have been performed with high rates of success for a variety of hematologic disorders and metabolic storage diseases in the pediatric setting. The results for adult umbilical cord blood transplantation have improved, with greater emphasis on cord blood units of sufficient cell dose and human leukocyte antigen match and with the use of double umbilical cord blood units and improved supportive care techniques. Cord blood expansion trials have recently shown improvement in time to engraftment. Umbilical cord blood is being compared with other graft sources in both retrospective and prospective trials. The growth of the field over the last 25 years and the plans for future exploration are discussed.

Entities:  

Mesh：

Year:  2013        PMID： 23673863      PMCID： PMC3952633          DOI： 10.1182/blood-2013-02-453175

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  89 in total

1.  Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.

Authors:  J Kurtzberg; M Laughlin; M L Graham; C Smith; J F Olson; E C Halperin; G Ciocci; C Carrier; C E Stevens; P Rubinstein
Journal:  N Engl J Med       Date:  1996-07-18       Impact factor: 91.245

2.  Double unrelated reduced-intensity umbilical cord blood transplantation in adults.

Authors:  Karen K Ballen; Thomas R Spitzer; Beow Y Yeap; Steven McAfee; Bimalangshu R Dey; Eyal Attar; Richard Haspel; Grace Kao; Deborah Liney; Edwin Alyea; Stephanie Lee; Corey Cutler; Vincent Ho; Robert Soiffer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

3.  Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group.

Authors:  F Locatelli; V Rocha; C Chastang; W Arcese; G Michel; M Abecasis; C Messina; J Ortega; I Badell-Serra; E Plouvier; G Souillet; J P Jouet; R Pasquini; E Ferreira; F Garnier; E Gluckman
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

4.  Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen.

Authors:  Satoshi Takahashi; Jun Ooi; Akira Tomonari; Takaaki Konuma; Nobuhiro Tsukada; Maki Oiwa-Monna; Kenji Fukuno; Michihiro Uchiyama; Kashiya Takasugi; Tohru Iseki; Arinobu Tojo; Takuhiro Yamaguchi; Shigetaka Asano
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

5.  Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.

Authors:  E Gluckman; V Rocha; A Boyer-Chammard; F Locatelli; W Arcese; R Pasquini; J Ortega; G Souillet; E Ferreira; J P Laporte; M Fernandez; C Chastang
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

6.  Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.

Authors:  J E Wagner; J Rosenthal; R Sweetman; X O Shu; S M Davies; N K Ramsay; P B McGlave; L Sender; M S Cairo
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

7.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors.

Authors:  P Rubinstein; C Carrier; A Scaradavou; J Kurtzberg; J Adamson; A R Migliaccio; R L Berkowitz; M Cabbad; N L Dobrila; P E Taylor; R E Rosenfield; C E Stevens
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

8.  Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease.

Authors:  J E Wagner; N A Kernan; M Steinbuch; H E Broxmeyer; E Gluckman
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

9.  Bone marrow transplantation for Fanconi anemia.

Authors:  E Gluckman; A D Auerbach; M M Horowitz; K A Sobocinski; R C Ash; M M Bortin; A Butturini; B M Camitta; R E Champlin; W Friedrich; R A Good; E C Gordon-Smith; R E Harris; J P Klein; J J Ortega; R Pasquini; N K Ramsay; B Speck; M R Vowels; M J Zhang; R P Gale
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

10.  Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes.

Authors:  T A Bock; D Orlic; C E Dunbar; H E Broxmeyer; D M Bodine
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307
View more
  195 in total

Review 1.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

2.  Human hematopoietic stem cells from mobilized peripheral blood can be purified based on CD49f integrin expression.

Authors:  Heather D Huntsman; Taha Bat; Hai Cheng; Ayla Cash; Patali S Cheruku; Jian-Fei Fu; Keyvan Keyvanfar; Richard W Childs; Cynthia E Dunbar; Andre Larochelle
Journal:  Blood       Date:  2015-09-24       Impact factor: 22.113

3.  A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies.

Authors:  U Sobol; A Go; S Kliethermes; S Bufalino; T Rodriguez; S Smith; M Parthasarathy; P Stiff
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

4.  Multicentre standardisation of a clinical grade procedure for the preparation of allogeneic platelet concentrates from umbilical cord blood.

Authors:  Paolo Rebulla; Simonetta Pupella; Michele Santodirocco; Noemi Greppi; Ida Villanova; Marina Buzzi; Nicola De Fazio; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-07-29       Impact factor: 3.443

Review 5.  A Need for Renewed and Cohesive US Policy on Cord Blood Banking.

Authors:  Monica M Matsumoto; Kirstin R W Matthews
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

6.  Biological Reference Interval for Hematological Profile of Umbilical Cord Blood: A Study Conducted at A Tertiary Care Centre in South India.

Authors:  Febe Renjitha Suman; Reddy S Sudheer Raj; N Priyathersini; Rithika Rajendran; Rashmika Rajendran; Umalakshmi Ramadoss
Journal:  J Clin Diagn Res       Date:  2015-10-01

7.  No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice.

Authors:  Mark van der Garde; Anneke Brand; Manon C Slot; Alice de Graaf-Dijkstra; Jaap Jan Zwaginga; Yvette van Hensbergen
Journal:  Stem Cells Dev       Date:  2015-03-13       Impact factor: 3.272

8.  Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.

Authors:  Sarah Anand; Samantha Thomas; Kelly Corbet; Cristina Gasparetto; Gwynn D Long; Richard Lopez; Ashley K Morris; David A Rizzieri; Keith M Sullivan; Anthony D Sung; Stefanie Sarantopoulos; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-17       Impact factor: 5.742

9.  Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia.

Authors:  Seitaro Terakura; Yachiyo Kuwatsuka; Junichi Sugita; Satoshi Takahashi; Yukiyasu Ozawa; Kazutaka Ozeki; Satoshi Yoshioka; Hirohisa Nakamae; Toshiro Kawakita; Masashi Sawa; Satoshi Morishige; Yuho Najima; Yuna Katsuoka; Emiko Sakaida; Yasuji Kouzai; Takafumi Kimura; Tatsuo Ichinohe; Takahiro Fukuda; Yoshiko Atsuta; Makoto Murata; Takanori Teshima
Journal:  Int J Hematol       Date:  2021-02-21       Impact factor: 2.490

10.  Reduction in Mortality after Umbilical Cord Blood Transplantation in Children Over a 20-Year Period (1995-2014).

Authors:  Lisa P Spees; Paul L Martin; Joanne Kurtzberg; Andre Stokhuyzen; Lauren McGill; Vinod K Prasad; Timothy A Driscoll; Suhag H Parikh; Kristin M Page; Richard Vinesett; Christopher Severyn; Anthony D Sung; Alan D Proia; Kirsten Jenkins; Mehreen Arshad; William J Steinbach; Patrick C Seed; Matthew S Kelly
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-24       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.